Beyond Fundamentals of HCT 2019

Houston, TX US
February 20, 2019 to February 21, 2019

Join the Beyond Fundamentals of HCT group February 20-21 for an extensive training program designed to provide practitioners with the skills required to care for patients undergoing HCT. The target audience for this course is pharmacists, pharmacy student and residents, physicians (including residents and hematology/oncology fellows), advanced practice providers and nurses. Offered simultaneously to the TCT Meetings of ASBMT & CIBMTR, this course will focus on pharmacotherapeautic management of HCT patients as well as patients receiving CAR-T therapy. 



This educational activity is being supported by an unrestricted educational grant:  Merck, Incyte, and Jazz Pharmaceuticals



Target Audience

Pharmacy students
Physicians (including residents and hematology/oncology fellows)
Advanced practice providers
Additional information

CME Coordinator Contact Information

Nicole Heino
Phone Number: 
+1 (763) 406-4811
Course summary
Available credit: 
  • 14.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 14.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
02/20/2019 - 8:00am
Event ends: 
02/21/2019 - 5:30pm



Day 1 - Wednesday, February 20, 2019

7:30 AM - 8:45 AMRegistration/Check-In Opens
8:45 AM - 9:00 AMWelcome - Opening Remarks
Topics in Autologous HCT
9:00 AM - 9:45 AMSession 1:
  • Hematopoietic Stem Cell Mobilization
(Lily Zhongyi Yan, PharmD; MD Anderson, Houston, TX)
9:45 AM - 10:30 AMSession 2:
  • Conditioning Regimens for Autologous HCT
(Eric Chow, PharmD, BCOP; Novant Health, Winston/Charlotte, NC) 
10:30 AM - 10:45 AMBreak
10:45 AM - 11:30 AMSession 3:
  • Peri-Engraftment Complications
  • Infectious Complications and Considerations
(Kelly Valla, PharmD, BCOP; Emory Health Care, Atlanta, GA)
CAR-T Therapy
11:30 AM - 12:00 PMSession 4: Overview of CAR-T Therapy
  • Background
  • Pathophysiology/Mechanisms
  • Indications
(Christina Bachmeier, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL)
12:00 PM -12:45 PMLunch
12:45 PM - 1:30 PMSession 5:
  • Toxicity Management of CAR-T Therapy
(Christina Bachmeier, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL)
Topics in Allogeneic HCT
1:30 PM - 2:45 PMSession 6: Conditioning Therapy to Day +30
  • Conditioning Regimens
  • Busulfan Pharmacokinetics
(Cathryn Jennissen, PharmD, BCOP; University of Minnesota Medical
Center, Fairview, Minneapolis MN)
2:45 PM - 3:00 PMBreak
3:00 PM - 3:45 PMSession 7: Conditioning Therapy to Day +30
  • Alternative Donor Regimens (haplo, cord)
(Cathryn Jennissen, PharmD, BCOP; University of Minnesota Medical
Center, Fairview, Minneapolis MN)
3:45 PM - 4:30 PMSession 8:
  • Conditioning Regimen to Day+30
  • Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome (VOD/SOS)
(Ashley Teusink-Cross, PharmD, MBA, BCPS; Cincinnati Children's
Hospital Medial Center; Cincinnati, Ohio)
4:30 PM - 5:15 PMSession 9:
  • Special Populations in HCT Panel Discussion
(Laura Whited, Ashley Teusink-cross, Cathryn Jennissen, Julianna Roddy)



Day 2 - Thursday, February 21, 2019


Overview of Allogeneic HCT (continued)
8:30 AM - 9:45 AMSession 10:
  • Acute GVHD Pathophysiology and Prophylactic Strategies
  • Management of Acute Steroid-Refractory GVHD
(Helen Leather, B.Pharm, BCPS; University of Florida College of Medicine and Principal, HLL Communications, Gainesville, FL)
9:45 AM - 10:00 AMBreak
10:00 AM - 11:15 AMSession 11: Day +31 to Day +100 (Non-Infectious Complications)
  • Transplant-Associated Thrombotic Microangiopathy (TMA)
(Cynthia Herrera, PharmD, BCPS, BCOP; Northwestern Memorial Hospital, Chicago, IL)
  • Immune-mediated cytopenias
(Susie Long, PharmD; University of Minnesota Medical Center, Fairview, Minneapolis MN)
11:15 AM - 12:15 PMSession 12: Day +31 to Day +100 (Infectious Complications)
  • Prophylaxis and Management of Viral Infections
(Ila Saunders, PharmD, BCOP; UC San Diego; Skaggs School of Pharmacy and Pharmaceutical Services, San Diego, CA)
12:15 PM - 1:00 PMLunch
1:00 PM - 2:00 PMSession 13: Day +31 to Day +100 (Infectious Complications)
  • Prophylaxis and Management of Fungal Infections
(Zahra Mahmoudjafari PharmD, University of Kansas Health System, Kansas City, KS)
2:00 PM - 3:00 PMSession 14: Day +100 and Beyond
  • Chronic GVHD
(Rebecca Gonzalez, PharmD; Moffitt Cancer Center, Tampa, FL)
3:00 PM - 3:15 PMBreak
3:15 PM - 5:00 PMSession 15: Day +100 and Beyond
  • Long-term Care
  • Vaccinations
(Julianna Roddy, PharmD, BCOP; James Cancer Hospital, The Ohio State University, Columbus, OH)
  • Complications/Survivorship
(Rachel Phelan, MD, Children's Hospital of Wisconsin, Milwaukee, WI)
  • Panel
(Rachel Phelan, Christina Ferraro, Kathy Hogan Edwards, Susannah Koontz)
Conference Concludes 




Hilton Americas
1600 Lamar St
Houston, TX 77010
United States


Houston’s Airport System is the 4th largest in the United States and offers two convenient airport options for attendees. Click here to view a map of the two airports. For more information, including recommendations for getting to and from the Hilton Americas-Houston and George R. Brown Convention Center (*GRB) please visit:

Distance to Hilton Americas-Houston and George R. Brown Convention Center:

  • George Bush Intercontinental (IAH) is approximately 22 miles
  • William P. Hobby (HOU) is approximately 11 miles
Planning Committee:
Michael Kent
Elizabeth Murphy
Julianna Roddy
Kelly Valla
Kelley Carlstrom
Laura Whited
Lily Zhongyi Yan
Eric Chow
Kelly Valla
Christina Bachmeier
Cathryn Jennissen
Ashley Teusink-Cross
Helen Leather
Cynthia Herrera
Ila Saunders
Zahra Mahmoudjafari
Rebecca Gonzalez
Rachel Phelan
Kathy Hogan Edwards
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  
Christina Bachmeier, PharmDKite, Gilead CompanyAdvisor/Steering Committee

Eric Chow, PharmD, BCOP



Pharmacy Times

Advisory Board

Advisory Board

Speaker/Peer reviewer

Ashley Teusink-Cross, PharmD, MBA, BCPS

Jazz Pharmaceuticals


Susannah Koontz, PharmD, BCOP, FHOPA

Cumberland Pharmaceuticals






Helen Leather, B.Pharm, BCPS

Clovis Oncology


Independent Contractor

Julianna Roddy, PharmD, BCOP


AbbVie/ Genentech

Heron Therapeutics

Advisory Board

Ila Saunders, PharmD, BCOP

Takeda Pharmaceuticals

Partner Therapeutics

Partner for Health Analytic Research

Magnolia Innovation

Advisory Board

Advisory Board

Independent contractor

Survey Participant

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and American Society for Blood and Marrow Transplantation. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 14.25 hours of participation for continuing education for allied health professionals.  

Available Credit

  • 14.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 14.25 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
Course expires: 


Please login or register to take this course.

Registration Information*

  • Before November 30: $425
  • After November 30: $475